AccueilSHPMF • OTCMKTS
add
Shanghai Pharmaceuticals Holding Co Ltd
Dernière clôture
1,18 $
Variation sur la journée
1,55 $ - 1,55 $
Plage sur l'année
0,99 $ - 1,95 $
Capitalisation boursière
70,21 Md HKD
Volume moyen
737,00
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Chiffre d'affaires | 70,22 Md | 8,16 % |
Charges d'exploitation | 4,31 Md | -4,78 % |
Résultat net | 1,11 Md | -6,29 % |
Marge bénéficiaire nette | 1,58 | -13,66 % |
Bénéfice par action | — | — |
EBITDA | 3,13 Md | 15,99 % |
Taux d'imposition effectif | 21,75 % | — |
Bilan
Total des actifs
Total du passif
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Trésorerie/Invest. court terme | 42,39 Md | 4,22 % |
Total des actifs | 223,74 Md | 4,97 % |
Total du passif | 140,58 Md | 5,70 % |
Total des capitaux propres | 83,16 Md | — |
Actions en circulation | 3,75 Md | — |
Ratio cours/valeur comptable | 0,06 | — |
Rentabilité des actifs | 3,14 % | — |
Retour sur capitaux | 5,13 % | — |
Flux de trésorerie
Variation nette en trésorerie
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Résultat net | 1,11 Md | -6,29 % |
Trésorerie (opérations) | 2,27 Md | 241,50 % |
Trésorerie (invest.) | -1,68 Md | -335,23 % |
Trésorerie (financement) | -3,63 Md | -55,26 % |
Variation nette en trésorerie | -3,05 Md | -44,04 % |
Flux de trésorerie dispo. | 3,82 Md | 177,98 % |
À propos
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Date de fondation
18 janv. 1994
Site Web
Employés
49 234
